Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly atovaquone-proguanil for malaria prophylaxis in controlled human malaria infection
2024-518884-36-00Phase 2Completed
- Sponsor
- University Hospital Tübingen
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in malaria comparing Weekly atovaquone-proguanil prophylaxis with Placebo control (2 arms). Primary endpoint: Proportion of protected volunteers. Started Nov 2025; status: completed.
02
Drugs
atovaquone + proguanil
03
Conditions
malaria
Beyond the preview
Go deeper on 2024-518884-36-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518884-36-00.